# Stereotaxis, Inc. Common Stock (STXS)

> Stereotaxis, Inc. Common Stock (STXS) trades at $0.9461 (+7.25%) as of 8:00:00 PM EST on Nov 18, 2026, -5.23% over the past month. Market cap is $95.42M, with 8.4 days to cover in short interest.

Canonical: https://massive.com/quote/stxs
Data as of: 2026-11-19T01:00:00.015Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$0.9461** +0.06 (+7.25%)
As of 8:00:00 PM EST on Nov 18, 2026 · 15-minute delayed
NYSE American · usd

## Stock performance

How Stereotaxis, Inc. Common Stock (STXS) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | +7.26% |
| 1W | +5.12% |
| 1M | -5.23% |
| YTD | -58.87% |
| 1Y | -57.76% |
| 52-wk range | $0.80 – $2.86 |

From daily closes through Nov 18, 2026.

## Key statistics

Today's trading snapshot for STXS: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $0.87 – $0.95 |
| Open | $0.89 |
| Prev close | $0.88 |
| Volume | 901.52K |
| Market cap | $95.42M |
| Shares out | 100.2M |

## Valuation and profitability ratios

Valuation and profitability ratios for Stereotaxis, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 3.04 |
| P/B | 3.61 |
| P/FCF | — |
| ROE | -89.0% |
| ROA | -28.7% |
| Debt/Equity | 0.09 |
| Div yield | 0.00% |

As of Nov 18, 2026

## Insider trading

[Stereotaxis, Inc. Common Stock (STXS) insider trading](https://massive.com/quote/stxs/insider-trading.md): open-market Form 4 buys and sells by Stereotaxis, Inc. Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events Stereotaxis, Inc. Common Stock has disclosed to the SEC on Form 8-K.

- Nov 10, 2026 · Debt issuance
  “On November 9, 2026, Stereotaxis, Inc., a Delaware corporation (the "Company"), entered into a Note Purchase Agreement (the "Purchase Agreement") with certain accredited investors, including entities affiliated with certain members of our board of directors (the "Investors"), pursuant to which the Company agreed to issue and sell to the Investors, and the Investor agreed to purchase from the Company, convertible promissory notes issued by the Company (each, a "Note" and collectively, the "Notes") in the aggregate original principal amount of up to $24.0 million (such financing, the "Note Financing") consisting of (i) Notes in the aggregate original principal amount of $12.0 million (the "Initial Notes") and (ii) additional Notes in the aggregate original principal amount of up to $12.0 million (the "Additional Notes"), subject to the satisfaction or waiver of the conditions set forth therein.”
- Jul 16, 2026 · Acquisition completion
  “on July 7, 2026, Stereotaxis, Inc. (the "Company") completed its acquisition (the "Acquisition") of shares and other securities collectively representing 100% of the share capital and voting power of Robocath, a French société par actions simplifiée, pursuant to that certain Share Sale Agreement, dated as of April 14, 2026”
- Jul 9, 2026 · Acquisition consideration shares
  “In connection with the Acquisition, the Company issued (i) 1,469,485 shares of its common stock, par value $0.001 per share (the "Common Stock") and (ii) "pre-funded" warrants (the "Purchaser Warrants") to purchase 4,575,143 shares of Common Stock to the securityholders of Robocath, in accordance with the terms and subject to the conditions set forth in the Share Sale Agreement.”
- Apr 15, 2026 · Acquisition agreement
  “On April 14, 2026, Stereotaxis, Inc. entered into a Share Sale Agreement with Robocath to acquire shares and other securities collectively representing 100% of the share capital and voting power of Robocath. The Company agreed to pay initial consideration of $20.0 million in cash and/or shares, plus additional earnout payments of up to $25 million if certain performance targets are met.”
- Aug 29, 2025 · Underwriting agreement
  “Roth Capital will be paid a placement fee of up to 3.0% of the gross sales price of the of the Shares sold pursuant the Sales Agreement. In addition, the Company has agreed to reimburse Roth Capital for certain specified expenses, including the fees and disbursements of its counsel in an amount not to exceed $50,000, in addition to certain ongoing disbursements not to exceed $5,000 per calendar quarter during any quarter in which sales pursuant to the Sales Agreement are made.”

## Dividend history and stock splits

Stereotaxis, Inc. Common Stock's recent dividend payments and stock splits.

### Dividends

No recent dividends.

### Splits

- 5-for-4 · Sep 15, 2015
- 1-for-10 · Jul 11, 2012

## STXS short interest

How heavily STXS is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 8.4 |
| Short interest | 5.56M |
| Avg volume | 661.22K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## STXS news

The latest news and headlines about Stereotaxis, Inc. Common Stock (STXS).

- [ISRG Is Expanding Beyond Surgery: Here's Why the GI Opportunity Matters](https://www.zacks.com/stock/news/3006358/isrg-is-expanding-beyond-surgery-here-s-why-the-gi-opportunity-matters?cid=CS-ZC-FT-analyst_blog|quick_take-3006358) · Zacks Investment Research · Oct 13, 2026 · positive sentiment
- [Stereotaxis Eyes Billions In Market Opportunity With Robocath Takeover](https://www.benzinga.com/m-a/26/04/51838474/stereotaxis-eyes-billions-in-market-opportunity-with-robocath-takeover?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel) · Benzinga · Apr 15, 2026 · positive sentiment
- [Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026](https://www.globenewswire.com/news-release/2026/02/12/3237239/21634/en/Stereotaxis-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-March-9-2026.html) · GlobeNewswire Inc. · Feb 12, 2026 · neutral sentiment
- [Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025](https://www.globenewswire.com/news-release/2025/10/21/3170237/21634/en/Stereotaxis-to-Report-Third-Quarter-2025-Financial-Results-on-November-11-2025.html) · GlobeNewswire Inc. · Oct 21, 2025 · neutral sentiment
- [Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025](https://www.globenewswire.com/news-release/2025/04/22/3065333/21634/en/Stereotaxis-to-Report-First-Quarter-2025-Financial-Results-on-May-12-2025.html) · GlobeNewswire Inc. · Apr 22, 2025 · positive sentiment

## About Stereotaxis, Inc. Common Stock

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

| Measure | Value |
| --- | --- |
| Exchange | NYSE American |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 131 |
| Listed | Aug 12, 2004 |

[Company website](https://www.stereotaxis.com)

## FAQ

### What is the Stereotaxis, Inc. Common Stock (STXS) stock price today?

Stereotaxis, Inc. Common Stock (STXS) is trading at $0.9461 (+7.25% on the day) as of 8:00:00 PM EST on Nov 18, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Stereotaxis, Inc. Common Stock?

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the…

### What is the short interest in STXS?

As of Oct 30, 2026, STXS has 5.56M shares short and 8.4 days to cover.

### What exchange is STXS listed on?

Stereotaxis, Inc. Common Stock (STXS) trades on NYSE American in USD, in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry.

## Live data

Prices here are 15-minute delayed. For real-time STXS quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=STXS`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Stereotaxis, Inc. Common Stock (STXS) insider trading](https://massive.com/quote/stxs/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
